Thermo Fisher Scientific targets $47.2B revenue and $24.80 EPS with 4% organic growth and Clario acquisition gains. Read why ...

By Chander Gupta Having retired from a Public Sector Bank after rendering service for 35 years as an officer, I am privileged ...

Hims & Hers is quietly building a healthcare platform, aiming to control the primary interface for diagnostics, prevention, and personalized treatments. Learn more.

Brex reports that recurring revenue, a predictable income stream, is key for modern business growth and stability, ...

Upgrade from quarterly payouts. This 7.2% dividend stock sends you a cheque every single month, and its payouts are growing.

The organizations that win in 2026 will be the ones that stopped asking how AI fits into their workflows and started ...

Homebuilding company PulteGroup (NYSE:PHM) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 6.3% year on year to $4.61 billion. Its GAAP profit of $2.56 per ...

Markets now move at machine speed. Technology is reshaping stock analysis from static reviews to live systems, forcing ...

Overview:  Focuses on high-dividend stocks that offer stable income and long-term holding potential.Highlights companies with ...

Shadowfax is commanding a tepid grey market premium, according to data from investorgain.com. Shadowfax IPO GMP today is ₹4.

Investors welcomed the Greenland agreement with relief, but the attack on JP Morgan raises new concerns. The Trump era is ...

Bad driving habits are adding cost to fleet service, maintenance and repair budgets, according to new research from Venson ...